Marketing Status
Source: National Cancer Institute Thesaurus
NCI Thesaurus OID: 2.16.840.1.113883.3.26.1.1
SPL Acceptable Term |
Code |
---|---|
Drug Sample | C96974 |
Marketing | C53292 |
Reserved | C211024 |
Cancelled | C211668 |
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
Source: National Cancer Institute Thesaurus
NCI Thesaurus OID: 2.16.840.1.113883.3.26.1.1
SPL Acceptable Term |
Code |
---|---|
Drug Sample | C96974 |
Marketing | C53292 |
Reserved | C211024 |
Cancelled | C211668 |